NMS Labs Announces Its New Chromium and Cobalt Test to Assist the Medical Community with Post Market Surveillance Studies on Metal Implant Exposure Cases

WILLOW GROVE, Pa.--(BUSINESS WIRE)--NMS Labs announces its launch of chromium and cobalt testing in blood, serum/plasma, and urine to help determine metal exposure in patients who have been implanted with recalled metal hips. Patients are at risk to exposure to chromium and cobalt components of the implants due to the rubbing together of metal-on-metal components. Such exposure can increase the body burden of these metals. Bio-monitoring of these metals may assist in the prevention of potential toxicities.